Universal Health Services/$UHS

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Universal Health Services

Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.

Ticker

$UHS
Sector

Primary listing

NYSE

Employees

99,300

UHS Metrics

BasicAdvanced
$15B
10.91
$21.01
1.31
$0.80
0.35%

What the Analysts think about UHS

Analyst ratings (Buy, Hold, Sell) for Universal Health Services stock.

Bulls say / Bears say

UHS’s adjusted earnings per share of $5.69 in Q3 2025 exceeded the $4.84 estimate, thanks to continued high demand for its hospital care services (Reuters).
The company raised its full-year 2025 revenue forecast to $17.31 billion–$17.45 billion, beating analyst expectations and reflecting strong operating momentum (Reuters).
UHS’s board approved a $1.5 billion boost to its stock buyback program, highlighting confidence in the company's cash generation and capital allocation strategy (Reuters).
Universal Health Services depends on Medicaid supplemental payment programs for 68% of its pretax income, making it vulnerable to proposed budget cuts by Republican lawmakers targeting these payments (WSJ).
In Q3 2025, UHS recorded a $35 million pre-tax charge to increase reserves for self-insured liabilities due to negative claims trends, indicating rising costs that could squeeze margins (Reuters).
Delays in billions of dollars of supplemental Medicaid payments under stricter CMS oversight have forced hospitals to use reserves and delay capital spending, creating liquidity risks for companies like UHS (WSJ).
Data summarised monthly by Lightyear AI. Last updated on 6 Nov 2025.

UHS Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

UHS Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $UHS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs